Why Anavex (AVXL) Is Down 50% Today: EMA Rejects Alzheimer's Drug Progress
Anavex stock plunged 50% in premarket trading after European regulators issued a negative vote on its Alzheimer's drug blarcamesine.The post Why Anavex (AVXL) Is Down 50% Today: EMA Rejects Alzheimer's Drug Progress appeared first on Tokenist.
🐂
—
🐻
